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PRELIMINARY EXPERIENCE OF NON-OCCUPATIONAL POST-EXPOSURE
PROPHYLAXIS (NPEP) IN TAIPEI
Chia-Jui Yang. Attending physician, Division of Infectious diseases,
Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei,
Taiwan
The use of antiretroviral drugs to prevent HIV infection through postexposure
prophylaxis (PEP) has been recommended since zidovudine was first found to
be associated with an 81% reduction in the odds of HIV infection following
percutaneous exposure among healthcare workers in a case-control study over
two decades ago. The concept of PEP was thus applied to non-occupational
exposure such as accidental exposure, noncoercive sex, and sexual assault.
Non-occupational PEP (nPEP) is usually prescribed as a 28-day course of
antiretroviral drugs that should be offered and initiated as early as possible to
all individuals with an exposure that has the potential for HIV transmission,
and ideally within 72 h. The efficacy and use of PEP is supported by data from
animal studies and trials demonstrating reduction of maternaleinfant trans-
mission. Clinical trials from different countries have demonstrated better
tolerability, completion rates, and fewer drugedrug interactions with newer
antiretroviral agents. Notably, there has been a shift from zidovudine-based
to tenofovir-based regimens. In Taiwan, increasing numbers of newly
diagnosed patients with HIV infection via sexual transmission were noted
since 2006. Thus we conducted nPEP as a part of the strategies of HIV
prevention since 2011 in Taipei. NPEP can be viewed as an educable moment
and an opportunity to identify high risk cases. We would like to share our
preliminary experience of nPEP in the prevention of HIV transmission.
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NOSOCOMIAL HIV INFECTIONS - LESSONS FROM HISTORY
Vladmir Krcmery a,b. aSt. Elizabeth University, Institute of Tropical
Medicine, Bratislava, 811 02, Slovakia; bSt. Max Kolbe Pediatric HIV
Institute, C 12334 Phnompenh, Cambodia
Purpose: HIV nosocomial infections in developing countries are extremely
rare due to strict preventive procedures in blood transfusion services super-
vised by government healthcare systems. However, several outbreaks of
nosocomial HIV has been described mainly from developing low or mid in-
come countries within last 20 years.
Methods: At least 3 large HIV nosocomial transmission outbreaks has been re-
ported either by scientific journals but before by themedia and political sources
before, from countries, where HIV and or AIDS is considered as societal or reli-
gious stigma from peoples Jammmaheeria in Lybia in 1999/2008, than from Re-
public of Kazakhstan town Shikment/Cikment in 2005/2007 and in 2011.
Results: 2012 fromRepublic Kyrgizistan, from3hospitals incentral land. Kyrgizi-
stan governmentwas the only onewhich letmedia and international health care
workers tocome inand independently investigate theoutbreaks,andputall chil-
dren (302) onHAART, thereforemore than 90 percent still alive in clinically good
condition. InLybia theoutbreakwasmisusedby thePresidentMuhammarKaddafi
tousepressure toBulgariaandEU,sincebulgariannurseswereaccusedanddeath
sentenced,with thehelp of international diplomacy (Bulgaria,Vatican, Slovakia,
Italy, France, etc) the death sentenced nurses were sent for execution to their
home country ale later released. All children in Benghazi Hospital and MissurataHospital Lybia, in time of our site visit received proper HAART and still alive on
therapy in good clinically condition.Third large outbreak in Kazakhstan city Shik-
mentwas refused tobe site visitedbyWHOorother internal teamandpart of the
children receive therapy but part not and many died. Common cause of those 3
major outbreaks in muslim religion predominant countries despite or relative
high level health care infrastructure have had intra venous drug use history in do-
nors and inadequate HIV testing practices in countries where HIV was not ex-
pected, and non indicated excessive use of blood product in therapy of trivial
ID. Several other small outbreaks of nosocomial HIV mainly in developing coun-
tries of Subsaharan Africa and South East Asia has been reported in 1985/1999
in time of limited diagnosis access and insufficient donor data. However, not
only developing countries has been affected with nosocomial HIV due to inade-
quate syringes supply (eg. Romania 1988).
Conclusions: Despite nosocomial outbreaks of HIV are currently historical
chapters in ID textbooks,lessons from those 4 outbreaks should be still
actual. Vigilance not only in countries with war conflicts and lot of blood
product use is warranted.
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RISK FACTOR FOR SEXUALLY TRANSMITTED DISEASES
Ryoichi Hamasuna, MD, PhD. Department of Urology, University of
Occupational and Environmental Health, Japan
Sexual intermitted infections (STIs)aretheuniversaldiseases,whicharedescribed
in many old records. Several pathogens for infectious disease can be transmitted
through sexual behaviors. The most popular STIs at the present time are male
urethritis and female cervicitis, which are mainly infected through peno-vaginal
sex between women and men. However, the sexual predilection are exchanged
and the risk factors for infection are also exchanged. STIs are transmittable
betweenmenandmenor femaleandfemale,orbyoral oranal sex. Inaddition, STI
pathogens, such as Neisseria gonorrhoeae or Mycoplasma genitalium have gotten
the antimicrobial resistance.. Especially the antimicrobial resistant of N. gonor-
rhoeaebecomeworldwideproblem.N.gonorrhoeaestrainsareoriginally sensitive
to any antimicrobials. However, the sensitivity for penicillin almost loosed. The
resistant rate against fluoroquinolone, tetracyclineor oral cephalosporin hasbeen
increasing, especially inAsia. It is knownthat thegeneticmutation inN. gonorrhea
strains can be induced by the antimicrobial pressure. In addition, the oral sex is
related to cephalosporin-resistance; N. gonorrhoeae can catch antimicrobial
resistant genomes fromNeisseria specimenswhich has antimicrobial resistance in
the normal flora of the oral cavity. Now, the recommended therapy in any STI
guideline is ceftriaxone injection.However, theceftriaxonehigh-level resistantN.
gonorrhoeae strains emerged from Japan or Europe. This strains were multi-drug
resistance and mutations or transformations on penA gene, which are related to
oral Neisseria species. WHO warned the increase in this untreatable gonorrhea.
The ceftriaxone therapy is still available, but the dosage of ceftriaxone for
gonococcal infection has not determined. High-dose such as 1g of ceftriaxone is
recommended for treatment against both genital and pharyngeal infection, but
somecountries cannot be accepted. Theantimicrobial resistanceofM. genitalium
is also increased. Macrolide-resistant M. genitalium strains increased in the world
and fluoroquinolone-resistant strains emerged. The recommended therapy for M.
genitalium infection has not been confirmed.
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ANTIMICROBIAL RESISTANCE IN URINARY TRACT INFECTIONS e ASIAN
DATA FROM THE GLOBAL PREVALENCE STUDY OF INFECTIONS IN
UROLOGY-GPIU
Seung-Ju Lee a, Hyun Sop Choe a, Yong-Hyun Cho b,*. aDepartment of
Urology, The Catholic University of Korea, St. Vincent’s Hospital, South
Korea; bDepartment of Urology, The Catholic University of Korea, Yeouido
St. Mary’s Hospital, South Korea
We present the Asian antibiotic resistance rates of uropathogens reported in
nosocomial urinary tract infections (NAUTI) during the period of 2004e2013.
Data from the Global Prevalence Study of Infections in Urology (GPIU) from
the period of 2004e2013 were analyzed to evaluate the resistance rates of
